Our Recommendations
- SARS-CoV-2 molecular assay evaluation: results (2020)
- Angezeigte Tests zum neuartigen Coronavirus (SARS-CoV-2) in Deutschland (2020)
- Coronavirus (COVID-19) - Cochrane Library (2020)
- Free access to COVID-19 publications by some publishers (2020)
- medRxiv- The preprint server for health sciences (2020)
Filter
57
Featured
Recommendations
11
New Publications
21
Language
Document type
Resource Platforms
35
Studies & Reports
7
Situation Updates
5
Online Courses
3
Fact sheets
3
No document type
2
Training Material
1
Guidelines
1
Countries / Regions
Germany
3
Russia
3
South Africa
2
China
1
Africa
1
Western and Central Europe
1
United Kingdom
1
Brazil
1
Authors & Publishers
Publication Years
Category
COVID-19
12
General Guidelines
1
Virology
1
Toolboxes
Scientific & Research Studies
57
Research & Pipeline
7
Country specific documents
6
Online Courses & Resources
5
Resource Platforms others
5
Dashboards & Resource Platforms
5
Clinical Aspects
3
Diagnostics & Laboratory Guidance
3
mRna Vaccines general
3
Vector-based Vacines General
3
Clinical Guidelines
2
PPE Personel Protective Equipment
2
Surveillance & Contact tracing
2
Training, others
2
Country-specific Platforms
2
Vaccine Candidates & Research
2
Public Health
1
For Health Worker
1
For Older People
1
Medical & Community Masks
1
Infographics for Health Worker
1
Essential Medicines & Medical Devices
1
SARS-CoV-2 Variants
1
Sputnik V
1
Other Resources
1
Capacity Building
1
On this site WHO is gathering the latest scientific findings and knowledge on coronavirus disease (COVID-19) and compiling it in a database. They are updating the database daily from searches of bibliographic databases, hand searches of the table of contents of relevant journals, and the addition of...
Free access to COVID-19 publications by some publishers namely Elsevier, JAMA, NEJM , CDC, Lancet, Cell, BMJ, Oxford, Nature, Wiley, Cambridge, medRvix
Coronavirus (COVID-19) - Cochrane Library
recommended
Cochrane provides high-quality, relevant, and up-to-date synthesized research evidence to inform health decisions. This page highlights content relating to the coronavirus (COVID-19) pandemic and the various related activities that Cochrane is undertaking in response.
They will be continually add...
Older people are at higher risk for more serious complications from COVID-19. COVID-19 is a new disease and we are learning more about it every day.
Evidencias COVID-19 es un recurso que ofrece información relevante relacionada con la pandemia del coronavirus SARS-CoV-2 y la COVID-19.
Este recurso recoge una serie de documentos que sintetizan la información más relevante para dar respuesta a preguntas clínicas y temas prioritarios sobre l...
Links to to summarised versions of Cochrane Reviews from EPOC and other groups that may be of particular relevance in pandemic situations such as COVID-19:
To help health- and social-system leaders as they respond to unprecedented challenges related to the COVID-19 pandemic, teams from the McMaster Health Forum and Ottawa Hospital Research Institute – as part of their contribution to RISE – and the Africa Centre for Evidence have compiled a list of...
This tracker, developed by the Vaccine Centre at the London School of Hygiene & Tropical Medicine, will follow COVID-19 vaccine candidates as they progress through the development pipeline. We will update it weekly. An overview of the different vaccine types as well as the phases of clinical develo...
A growing number of studies and reports are being published on COVID-19 and the pandemic. This project will help decision makers and researchers navigate the research.
It provides an overview of scientific publications on COVID-19 categorized and parsed into more specific subgroups, providing quick...
Le CNRS se mobilise pour vous donner des informations scientifiques fiables sur la pandémie du coronavirus COVID-19
Das Kompetenznetz Public Health zu COVID-19 ist ein Ad hoc-Zusammenschluss von über 25 wissenschaftlichen Fachgesellschaften aus dem Bereich Public Health, die hier ihre, methodische, epidemiologische, statistische, sozialwissenschaftliche und (bevölkerungs-)medizinische Fachkenntnis bündeln. Gem...
SARS-CoV-2 molecular assay evaluation: results
recommended
FIND conducted independent evaluations at the University Hospitals of Geneva (HUG), to verify the limit of detection (LOD) and the clinical performance (as reported by the manufacturers) of the following molecular test kits. The LOD analysis was performed using cultured viral stocks from a clinical ...
Tests zur Detektion einer Infektion mit SARS-CoV-2 (neuartiges Coronavirus) sowie zum Nachweis von Antikörpern gehören zu den sog. In-vitro-Diagnostika (IVD). Das erstmalige Inverkehrbringen von In-vitro-Diagnostika auf dem deutschen Markt ist nach §§ 25 und 30 Medizinproduktegesetz (MPG) anzeig...
The key objective is to celebrate, source, and supply innovations across 12 COVID-19 categories (i.e. response areas). The growing list of 800+ featured innovations includes those that are ready to deploy, plus innovations that could be adapted for COVID-19 responses, or inspire new, much-needed sol...
Solidarity” is an international clinical trial to help find an effective treatment for COVID-19, launched by the World Health Organization and partners.
The Solidarity Trial will compare four treatment options against standard of care, to assess their relative effectiveness against COVID-19. By...
A lot of research articles concerning SARS-CoV-2/COVID-19 are published every day. Many of them, so-called pre-prints, are not reviewed in a professional reviewing process at the time of publication. Others are already reviewed and published in well-known journals. Collabovid helps researchers to id...
There is no secret to our procedure: the daily scanning of the literature helps us to stay afloat in the never-ending waves of new publications about SARS-CoV-2 and COVID-19. Many papers discussed in the Top 10 will eventually make it into subsequent editions of COVID Reference.
Top 20 on Face Masks
recommended
Almost all organizations recommend masks for the general public. Unfortunately, earlier in the pandemic, many did exactly the opposite – due to limited data but also due to concerns about diminished mask supply for healthcare workers and out of fear that masked individuals might be tempted to igno...
